Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling-Reference-Cited by-同舟云学术

Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

Published:2015-10-09 Issue:3 Volume:56 Page:266-283
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Upreti Vijay V.¹,Wahlstrom Jan L.²

Affiliation:

1. Clinical Pharmacology, Modeling and Simulation; Amgen, Inc.; South San Francisco CA USA

2. Pharmacokinetics and Drug Metabolism; Amgen, Inc.; Thousand Oaks CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.585/fullpdf

Reference178 articles.

1. Practical considerations for dose selection in pediatric patients to ensure target exposure requirements;Barbour;AAPS J,2014

2. Developmental pharmacology-drug disposition, action, and therapy in infants and children;Kearns;N Engl J Med,2003

3. Pediatric drug formulations: a review of challenges and progress;Ivanovska;Pediatrics,2014

4. Physiologically based pharmacokinetic (PBPK) modeling in children;Barrett;Clin Pharmacol Ther,2012

5. Predicting in vivo drug interactions from in vitro drug discovery data;Wienkers;Nature reviews. Drug Discov,2005

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of enteroids derived from children and adults to study age-dependent differences in intestinal CYP3A4/5 metabolism;European Journal of Pharmaceutical Sciences;2024-10

2. Developmental Expression of Drug Transporters and Conjugating Enzymes Involved in Enterohepatic Recycling: Implication for Pediatric Drug Dosing;Clinical Pharmacology & Therapeutics;2024-08-19

3. Hepatic Metabolic Enzyme Activity with Endogenous Substances-current Status, Challenges and Limitations;Current Drug Metabolism;2024-08-16

4. PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co‐Administered with CYP3A4 Inhibitors;Clinical Pharmacology & Therapeutics;2024-07-18

5. Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of concept;Frontiers in Pediatrics;2024-07-05